Please assess the completion status of the following clinical trial:

Trial Title: Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women aged 18 or more including following conditions~  * Family history of gastric cancer~ * Post endoscopic resection status for early gastric cancer or adenoma~ * Peptic ulcer disease (benign gastric ulcer and duodenal ulcer)~ * Chronic gastritis~ * Non-ulcer dyspepsia~ * Healthy adults who want to receive H. pylori treatment~* H. pylori positive by urea breath test, histology, or rapid urease test~Exclusion Criteria:~* History of H. pylori eradication therapy~* History of stomach operation~* Other organ cancer within 5 years~* Liver cirrhosis or Hepatic insufficiency~* Renal insufficiency~* Current treatment for serious medical condition which may hinder participation~* Contraindication or allergy history for H. pylori treatment regimens~* Mental incompetence to understand and sign informed consent~* Incompatible conditions to be included into the trial by investigators' decision~* Inability to provide an informed consent~* History of treatment for peptic ulcer disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Standard triple therapy (Type: ACTIVE_COMPARATOR): 7 day-PPI based standard triple therapy
- Bismuth quadruple therapy (Type: ACTIVE_COMPARATOR): 10 day-bismuth quadruple therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).